Drug-Drug Interaction Between Praziquantel and Nevirapine in HIV-Schistosomiasis Co-infection: A Pharmacokinetic case report
Clicks: 24
ID: 322356
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
6.9
/100
24 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #14 of 52 articles by views in international journal of travel medicine and global health
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Highlights Praziquantel (PZQ) is metabolized predominantly by CYP450 enzymes.Nevirapine (NVP) is a moderate inducer of CYP3A4 and CYP2B6.NVP and PZQ drug interactions have not been described.Our results indicate an absence of significant clinical or pharmacokinetic interaction between PZQ and NVP
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (45 words).
Try re-searching for a better abstract.
| Reference Key |
openalex_W7170141935
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Arthur Lefevre, Lê Mg, Hélène Marty, Gilles Peytavin, Firouzé Bani‐Sadr |
| Journal | international journal of travel medicine and global health |
| Year | 2026 |
| DOI |
10.1093/jtm/taag066
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.